Sichuan Hebang Biotechnology Corporation Limited (603077.SS)
CNY 1.71
(-1.16%)
CNY 1.71
(-1.16%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 24.54 Billion CNY | 1.82% |
| 2022 | 24.1 Billion CNY | 34.48% |
| 2021 | 17.92 Billion CNY | 21.59% |
| 2020 | 14.74 Billion CNY | 1.77% |
| 2019 | 14.48 Billion CNY | 9.01% |
| 2018 | 13.28 Billion CNY | 1.36% |
| 2017 | 13.1 Billion CNY | 1.4% |
| 2016 | 12.92 Billion CNY | 15.45% |
| 2015 | 11.19 Billion CNY | 22.62% |
| 2014 | 9.13 Billion CNY | 63.59% |
| 2013 | 5.58 Billion CNY | 10.62% |
| 2012 | 5.04 Billion CNY | 37.05% |
| 2011 | 3.68 Billion CNY | 18.06% |
| 2010 | 3.11 Billion CNY | -1.52% |
| 2009 | 3.16 Billion CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 25.63 Billion CNY | 4.47% |
| 2024 Q2 | 26.22 Billion CNY | 2.28% |
| 2024 Q3 | 25.97 Billion CNY | -0.94% |
| 2023 Q2 | 23.71 Billion CNY | -1.34% |
| 2023 FY | 24.54 Billion CNY | 1.82% |
| 2023 Q4 | 24.54 Billion CNY | -1.28% |
| 2023 Q3 | 24.86 Billion CNY | 4.83% |
| 2023 Q1 | 24.03 Billion CNY | -0.27% |
| 2022 Q3 | 23 Billion CNY | 3.39% |
| 2022 Q2 | 22.24 Billion CNY | 12.73% |
| 2022 Q1 | 19.73 Billion CNY | 10.12% |
| 2022 FY | 24.1 Billion CNY | 34.48% |
| 2022 Q4 | 24.1 Billion CNY | 4.78% |
| 2021 FY | 17.92 Billion CNY | 21.59% |
| 2021 Q4 | 17.92 Billion CNY | 7.24% |
| 2021 Q2 | 15.58 Billion CNY | 6.35% |
| 2021 Q3 | 16.71 Billion CNY | 7.26% |
| 2021 Q1 | 14.65 Billion CNY | -0.6% |
| 2020 Q3 | 14.45 Billion CNY | -0.93% |
| 2020 FY | 14.74 Billion CNY | 1.77% |
| 2020 Q1 | 14.55 Billion CNY | 0.47% |
| 2020 Q2 | 14.58 Billion CNY | 0.24% |
| 2020 Q4 | 14.74 Billion CNY | 1.99% |
| 2019 Q3 | 14.31 Billion CNY | 4.02% |
| 2019 Q2 | 13.75 Billion CNY | 2.88% |
| 2019 Q1 | 13.37 Billion CNY | 0.64% |
| 2019 FY | 14.48 Billion CNY | 9.01% |
| 2019 Q4 | 14.48 Billion CNY | 1.21% |
| 2018 FY | 13.28 Billion CNY | 1.36% |
| 2018 Q4 | 13.28 Billion CNY | -5.8% |
| 2018 Q3 | 14.1 Billion CNY | 8.06% |
| 2018 Q2 | 13.05 Billion CNY | -0.04% |
| 2018 Q1 | 13.05 Billion CNY | -0.39% |
| 2017 Q4 | 13.1 Billion CNY | 0.28% |
| 2017 FY | 13.1 Billion CNY | 1.4% |
| 2017 Q3 | 13.07 Billion CNY | 0.58% |
| 2017 Q2 | 12.99 Billion CNY | 0.15% |
| 2017 Q1 | 12.97 Billion CNY | 0.39% |
| 2016 Q3 | 15.15 Billion CNY | 33.36% |
| 2016 Q4 | 12.92 Billion CNY | -14.69% |
| 2016 Q1 | 11.3 Billion CNY | 0.97% |
| 2016 FY | 12.92 Billion CNY | 15.45% |
| 2016 Q2 | 11.36 Billion CNY | 0.51% |
| 2015 FY | 11.19 Billion CNY | 22.62% |
| 2015 Q1 | 9.3 Billion CNY | 1.85% |
| 2015 Q4 | 11.19 Billion CNY | 11.14% |
| 2015 Q3 | 10.07 Billion CNY | -2.24% |
| 2015 Q2 | 10.3 Billion CNY | 10.81% |
| 2014 FY | 9.13 Billion CNY | 63.59% |
| 2014 Q3 | 8.76 Billion CNY | -0.55% |
| 2014 Q4 | 9.13 Billion CNY | 4.19% |
| 2014 Q2 | 8.81 Billion CNY | 56.62% |
| 2014 Q1 | 5.62 Billion CNY | 0.8% |
| 2013 Q1 | 4.94 Billion CNY | -1.99% |
| 2013 Q2 | 5.2 Billion CNY | 5.31% |
| 2013 Q3 | 5.47 Billion CNY | 5.1% |
| 2013 Q4 | 5.58 Billion CNY | 1.98% |
| 2013 FY | 5.58 Billion CNY | 10.62% |
| 2012 FY | 5.04 Billion CNY | 37.05% |
| 2012 Q4 | 5.04 Billion CNY | -3.99% |
| 2012 Q3 | 5.25 Billion CNY | 43.4% |
| 2012 Q2 | 3.66 Billion CNY | 0.0% |
| 2011 FY | 3.68 Billion CNY | 18.06% |
| 2011 Q4 | 3.68 Billion CNY | 0.0% |
| 2010 FY | 3.11 Billion CNY | -1.52% |
| 2009 FY | 3.16 Billion CNY | 0.0% |